<PAGE>

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-K/A

                                (Amendment No. 3)

[X]      ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
         EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2000.

                                       OR

[ ]      TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
         EXCHANGE ACT OF  1934 FOR THE TRANSITION PERIOD FROM ____ to ____

                         Commission file number 0-25852

                           THE MED-DESIGN CORPORATION
                    (Name of business issuer in its charter)
<TABLE>
<CAPTION>
<S>                                                                       <C>
                         Delaware                                                       23-2771475
(State or other jurisdiction of incorporation or organization)            (I.R.S. Employer Identification No.)
</TABLE>

             2810 Bunsen Avenue, Ventura, CA              93003
         (Address of principal executive offices)      (Zip Code)

       Registrant's telephone number, including area code: (805) 339-0375

           Securities registered pursuant to Section 12(b) of the Act:

                               Title of each class

                                      None

           Securities registered pursuant to Section 12(g) of the Act:

                     Common Stock, Par Value $0.01 Per Share
                                (Title of Class)

Indicate by check mark whether the registrant: (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes _X_  No__

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405
of Regulation S-K is not contained herein, and will not be contained, to the
best of registrant's knowledge, in the definitive proxy or information
statements incorporated by reference in Part III of this form 10-K or any
amendment to this Form 10-K [ ].

The aggregate market value of voting stock held by non-affiliates of the
Registrant (computed by reference to the last reported sale price of such stock
on April 25, 2001) was $139,047,889. For purposes of making this calculation
only, the Registrant has defined "affiliates" as including all directors and
executive officers (including any executive officers who have terminated their
employment with the Registrant within the past 90 days). The number of shares of
Registrant's common stock outstanding as of April 25, 2001 was 10,589,520.

Documents incorporated by reference:

None

PRELIMINARY NOTE:

This Form 10-K/A is being filed to amend and restate Item 2 of Part I of the
Company's 10-K filed with the Commission on March 23, 2001.

                                       1



<PAGE>


ITEM 2. DESCRIPTION OF PROPERTIES

         We have leased an approximately 26,000 square foot facility in Ventura,
California. In addition to our corporate offices, the facility includes space
for the following:

o    a research and development laboratory equipped with assembly and test
     equipment for concept modeling and product development;

o    a machine shop equipped with tools for the fabrication of new product parts
     for concept modeling and assembly, as well as the fabrication of prototype
     molds and test fixtures;

o    a 3,120 square foot class 100,000 clean room used for the assembly of
     prototypes; and

o    a semi-automated assembly system, which consists of a series of manual and
     semi-automatic stations.

The assembly system is currently being used to manufacture limited quantities of
our products to demonstrate to potential third-party manufacturers the economic
feasibility of the commercial production of our products. With some
modifications, the semi-automated assembly system is capable of producing up to
6,000,000 units per year and can produce one or more of our products at a time.
This assembly system will enable us to manufacture the products we design for
certain niche markets which do not involve the same manufacturing scale as more
widely used products, such as those licensed to Becton Dickinson.

Our annual lease payments for this facility are approximately $149,712 and the
lease expires on October 31, 2003.








                                       2


<PAGE>
                                   SIGNATURES

         Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.

                                      THE MED-DESIGN CORPORATION

Dated: June 4, 2001                   By: /s/  Joseph N. Bongiovanni, III
                                          -------------------------------------
                                          Joseph N. Bongiovanni, III
                                          Secretary









                                       3